
Esovag 40mg Injection
Marketer
Prevego Healthcare & Research Private Limited
Salt Composition
Esomeprazole (40mg)
Overview Esovag 40mg Injection
Intravenous Esovag 40mg reduces gastric acid secretion. It treats acid-related gastrointestinal disorders like reflux and other hyperacidity conditions. Prophylactically, it's used to prevent stress ulcers in critically ill patients and pre-anesthesia to mitigate aspiration risks. Classified as a proton pump inhibitor (PPI), this medication is administered intravenously by a medical professional only when deemed clinically superior to oral administration. Dosage and treatment duration are determined by your physician based on individual needs and response. Lifestyle modifications, including frequent small meals and avoidance of caffeine, spicy, and fatty foods, can enhance treatment effectiveness. Common side effects may include injection site reactions, nausea, headache, dizziness, gas, diarrhea, abdominal pain, and fundic gland polyps; these are usually mild, but persistent or bothersome symptoms warrant medical attention. Discuss bone health with your doctor, considering calcium and vitamin D supplementation to mitigate potential osteoporosis. Esovag 40mg injection is contraindicated in individuals with severe hepatic impairment, those on HIV medications, those with a history of PPI allergy, or existing osteoporosis. Pregnant or lactating individuals should seek medical advice before use. Alcohol consumption should be avoided due to its potential to exacerbate acid production and symptoms.
Primary Ingredients of Esovag 40mg Injection
No text was provided. Please provide the text you wish to be rephrased.
Uses of Esovag 40mg Injection
Managing gastroesophageal reflux disease (GERD)
Major Benefits of Esovag 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Esovag 40mg Injection:
- Injection site reaction
- Headache
- Dizziness
- Dryness in mouth
- Nausea
- Abdominal pain
- Constipation
- Flatulence
- Diarrhea
- Fundic gland polyps
How to use Esovag 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Esovag 40mg Injection works:
Esomeprazole 40mg Injection, a proton pump inhibitor, decreases gastric acid production, providing relief from acid indigestion and heartburn symptoms.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Esovag 40mg Injection concurrently with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Using Esovag 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Esovag 40mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Esovag 40mg Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
The administration of Esovag 40mg Injection warrants careful consideration in individuals exhibiting severe renal impairment. A modified dosage of Esovag 40mg Injection may be necessary. Physician consultation is advised. Dosage modification is unnecessary for patients with mild to moderate kidney disease.
LiverCAUTION
For patients with severe hepatic impairment, Esovag 40mg Injection requires careful administration and potential dose modification. Individuals with mild to moderate liver disease do not necessitate dosage alteration. Physician consultation is advised.
What if you forget to take Esovag 40mg Injection :
Omitting a scheduled Esovag 40mg Injection requires immediate physician consultation.
Facts to Know About Esovag 40mg Injection
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | Gastric acid suppressants |
